2023 Form 5500 filing — Sutro Biopharma, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241015153043NAL0030173553001) for Sutro Biopharma, Inc. 401(K) Plan, reported by Sutro Biopharma, Inc. under EIN 47-0926186 and plan number 001. It reports 353 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241015153043NAL0030173553001
Filing year
2023
Form type
2
Plan sponsor
Sutro Biopharma, Inc.
EIN
47-0926186
Plan number
001
Location
South San Francisco, CA
Participants
353
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$31,471,842
Total liabilities (EOY)
$0
Net assets (EOY)
$31,471,842
Employer contributions
$1,019,640
Participant contributions
$5,188,195
Total income / additions
$12,490,402
Benefits paid
$1,516,632
Administrative expenses
$113,808
Total expenses
$1,630,440
Net increase / (decrease)
$10,859,962
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Onedigital Investment Advisors LLCRETIREMENT PLAN CONSULTAN$40,662not reported in the loaded dataset
Adp, Inc.RECORDKEEPER$28,228not reported in the loaded dataset
Fidelity Investments InstitutionalRECORDKEEPER$1,482$0
Adp Broker-DealerRECORDKEEPER$1,019not reported in the loaded dataset

Related Form 5500 pages